End of life detection for analyte sensors
US-2016302701-A1 · Oct 20, 2016 · US
US12326441B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12326441-B2 |
| Application number | US-202318493731-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 24, 2023 |
| Priority date | May 14, 2007 |
| Publication date | Jun 10, 2025 |
| Grant date | Jun 10, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
Opening claim text (preview).
What is claimed is: 1. A glucose monitoring system, comprising: a glucose sensor including a first portion configured to be positioned above a skin layer of the user, and a second portion configured to be implanted transcutaneously below the skin layer of the user into a subcutaneous space and in contact with an interstitial fluid of the user and having a working electrode, and a reference electrode, wherein the glucose sensor is configured to generate data signals associated with a glucose level of the interstitial fluid; one or more processors; and one or more memories storing a sensor code from manufacturing, wherein the memories are operatively coupled to the one or more processors for storing instructions which, when executed by the one or more processors, cause the one or more processors to: retrieve a sensitivity and a predefined sensitivity range from the sensor code from manufacturing; receive an unscheduled manual user calibration; determine a composite sensitivity using a time based function based on the sensitivity, the predefined sensitivity range, and the unscheduled manual user calibration; and determine a glucose level of the user based on the composite sensitivity and the data signals generated by the glucose sensor. 2. The glucose monitoring system of claim 1 , wherein the unscheduled manual user calibration comprises causing a user input interface to be provided for display; and receiving a current blood glucose value from the user input interface. 3. The glucose monitoring system of claim 1 , wherein the one or more processors and one or more memories are disposed within a transmitter unit. 4. The glucose monitoring system of claim 3 , wherein the transmitter unit further comprises a first temperature sensor. 5. The glucose monitoring system of claim 4 , wherein the instructions further cause the glucose level of the user to be based on a temperature reading from the first temperature sensor. 6. The glucose monitoring system of claim 5 , wherein the transmitter unit further comprises a second temperature sensor. 7. The glucose monitoring system of claim 6 , wherein the first temperature sensor is located at a first location within the transmitter unit and the second temperature sensor is located at a second location within the transmitter unit, wherein the first location is different than the second location. 8. The glucose monitoring system of claim 1 , wherein the instructions further perform an associate routine. 9. The glucose monitoring system of claim 8 , wherein the associate routine includes a data quality check. 10. The glucose monitoring system of claim 8 , wherein the associate routine includes a glucose rate of change verification. 11. The glucose monitoring system of claim 8 , wherein the associate routine includes digital filtering of the data signals.
for data related to laboratory analysis, e.g. patient specimen analysis · CPC title
relating to drugs or medications, e.g. for ensuring correct administration to patients · CPC title
for remote operation · CPC title
ICT specially adapted for medical reports, e.g. generation or transmission thereof · CPC title
for simulation or modelling of medical disorders · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.